Cambridge Nutritional Sciences plc

AIM:CNSL Stock Report

Market Cap: UK£7.4m

Cambridge Nutritional Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

James Cooper

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure7.1yrs
Board average tenure1.4yrs

Recent management updates

Recent updates

Investors Don't See Light At End Of Cambridge Nutritional Sciences plc's (LON:CNSL) Tunnel

Nov 19
Investors Don't See Light At End Of Cambridge Nutritional Sciences plc's (LON:CNSL) Tunnel

The Market Doesn't Like What It Sees From Cambridge Nutritional Sciences plc's (LON:CNSL) Revenues Yet

Jul 27
The Market Doesn't Like What It Sees From Cambridge Nutritional Sciences plc's (LON:CNSL) Revenues Yet

Cambridge Nutritional Sciences plc's (LON:CNSL) Shares Lagging The Industry But So Is The Business

Mar 14
Cambridge Nutritional Sciences plc's (LON:CNSL) Shares Lagging The Industry But So Is The Business

We Think Omega Diagnostics Group (LON:ODX) Needs To Drive Business Growth Carefully

Nov 06
We Think Omega Diagnostics Group (LON:ODX) Needs To Drive Business Growth Carefully

This Is Why Omega Diagnostics Group PLC's (LON:ODX) CEO Compensation Looks Appropriate

Sep 09
This Is Why Omega Diagnostics Group PLC's (LON:ODX) CEO Compensation Looks Appropriate

Companies Like Omega Diagnostics Group (LON:ODX) Are In A Position To Invest In Growth

Jun 14
Companies Like Omega Diagnostics Group (LON:ODX) Are In A Position To Invest In Growth

How Does Omega Diagnostics Group's (LON:ODX) CEO Salary Compare to Peers?

Mar 01
How Does Omega Diagnostics Group's (LON:ODX) CEO Salary Compare to Peers?

Announcing: Omega Diagnostics Group (LON:ODX) Stock Soared An Exciting 301% In The Last Year

Feb 01
Announcing: Omega Diagnostics Group (LON:ODX) Stock Soared An Exciting 301% In The Last Year

What You Need To Know About Omega Diagnostics Group PLC's (LON:ODX) Investor Composition

Jan 04
What You Need To Know About Omega Diagnostics Group PLC's (LON:ODX) Investor Composition

We're Hopeful That Omega Diagnostics Group (LON:ODX) Will Use Its Cash Wisely

Dec 09
We're Hopeful That Omega Diagnostics Group (LON:ODX) Will Use Its Cash Wisely

CEO

James Cooper (33 yo)

less than a year

Tenure

Mr. James Cooper had been Chief Operating Officer of Cambridge Nutritional Sciences plc since May 24, 2024 until 2024 and is its Executive Director since May 24, 2024 and has been its Interim CEO since Aug...


Leadership Team

NamePositionTenureCompensationOwnership
James Cooper
Interim CEO & Executive Directorless than a yearno datano data
Iain Alexander Logan
Group Financial Controller14.2yrsno datano data
Prashant Maniar
Managing Director of Omega Dx Asia Pvt Limited13.3yrsno datano data
Charlene Roderman
Company Secretaryless than a yearno datano data
Andrew Shepherd
Global Ambassador - Life Presidentno dataUK£317.15kno data

7.1yrs

Average Tenure

51yo

Average Age

Experienced Management: CNSL's management team is seasoned and experienced (7.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Cooper
Interim CEO & Executive Directorless than a yearno datano data
Jeremy Millard
Independent Non-Executive Director5.8yrsUK£37.00k0.43%
£ 31.8k
Carolyn Rand
Independent Non-Executive Chair1.4yrsUK£113.00kno data

1.4yrs

Average Tenure

53yo

Average Age

Experienced Board: CNSL's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 03:42
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cambridge Nutritional Sciences plc is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adam McCarterCavendish
Ian BerryCavendish Historical (Cenkos Securities)
John SavinEdison Investment Research